Contact
Please use this form to send email to PR contact of this press release:
Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression
TO:
Please use this form to send email to PR contact of this press release:
Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression
TO: